Literature DB >> 23847297

Weakness and fatigue in diverse neuromuscular diseases.

Jacqueline Montes1, Michelle Blumenschine, Sally Dunaway, Aliza S Alter, Kristin Engelstad, Ashwini K Rao, Claudia A Chiriboga, Douglas M Sproule, Darryl C De Vivo.   

Abstract

Weakness and fatigue are captured by the 6-minute walk test, but the relationship between these symptoms is uncertain. Comparison across neuromuscular diseases has not been examined. A cohort study of 114 patients with spinal muscular atrophy, Duchenne/Becker muscular dystrophy, myasthenia gravis, and energy failure syndromes were included. Percent-predicted distance on the 6-minute walk test was computed from normative values to determine weakness. Fatigue was determined by the decrement in distance from the first to sixth minute. Weakness was seen across all groups (61.9%) but significant fatigue was seen only in spinal muscular atrophy (21.0%). Other groups showed little fatigue. Correlation between weakness and fatigue was significant only in spinal muscular atrophy (R = -0.71; P < .001). Longitudinally, distance walked declined only in Duchenne/Becker muscular dystrophy. In spinal muscular atrophy, weakness did not change, but fatigue increased significantly. These findings suggest independent mechanisms underlying weakness and fatigue in diverse neuromuscular conditions.

Entities:  

Keywords:  6-minute walk test; fatigue; neuromuscular disease; spinal muscular atrophy; weakness

Mesh:

Year:  2013        PMID: 23847297     DOI: 10.1177/0883073813493663

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  14 in total

1.  Drug treatment for spinal muscular atrophy types II and III.

Authors:  Renske I Wadman; W Ludo van der Pol; Wendy Mj Bosboom; Fay-Lynn Asselman; Leonard H van den Berg; Susan T Iannaccone; Alexander Fje Vrancken
Journal:  Cochrane Database Syst Rev       Date:  2020-01-06

2.  Suite of clinically relevant functional assays to address therapeutic efficacy and disease mechanism in the dystrophic mdx mouse.

Authors:  Yafeng Song; Shira T Rosenblum; Leon Morales; Mihail Petrov; Christopher Greer; Samantha Globerman; Hansell H Stedman
Journal:  J Appl Physiol (1985)       Date:  2016-12-08

3.  Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.

Authors:  Suzan M Hammond; Gareth Hazell; Fazel Shabanpoor; Amer F Saleh; Melissa Bowerman; James N Sleigh; Katharina E Meijboom; Haiyan Zhou; Francesco Muntoni; Kevin Talbot; Michael J Gait; Matthew J A Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

4.  Limitations of 6-minute walk test reference values for spinal muscular atrophy.

Authors:  Ashley M Goodwin; Kayla M D Cornett; Marnee J McKay; Joshua Burns; Carol Ewing Garber; Darryl C De Vivo; Jacqueline Montes
Journal:  Muscle Nerve       Date:  2020-01-16       Impact factor: 3.217

5.  Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy.

Authors:  Jacqueline Montes; Ashley M Goodwin; Michael P McDermott; David Uher; Feliz Marie Hernandez; Kayla Coutts; Julia Cocchi; Margarethe Hauschildt; Kayla M Cornett; Ashwini K Rao; Umrao R Monani; Carol Ewing Garber; Darryl C De Vivo
Journal:  Ann Clin Transl Neurol       Date:  2021-03-31       Impact factor: 5.430

6.  6MWT Performance and its Correlations with VO₂ and Handgrip Strength in Home-Dwelling Mid-Aged and Older Chinese.

Authors:  Qing Zhang; Hailin Lu; Shiqin Pan; Yuan Lin; Kun Zhou; Li Wang
Journal:  Int J Environ Res Public Health       Date:  2017-04-29       Impact factor: 3.390

7.  Ambulatory function in spinal muscular atrophy: Age-related patterns of progression.

Authors:  Jacqueline Montes; Michael P McDermott; Elizabeth Mirek; Elena S Mazzone; Marion Main; Allan M Glanzman; Tina Duong; Sally Dunaway Young; Rachel Salazar; Amy Pasternak; Richard Gee; Roberto De Sanctis; Giorgia Coratti; Nicola Forcina; Lavinia Fanelli; Danielle Ramsey; Evelin Milev; Matthew Civitello; Marika Pane; Maria Carmela Pera; Mariacristina Scoto; John W Day; Gihan Tennekoon; Richard S Finkel; Basil T Darras; Francesco Muntoni; Darryl C De Vivo; Eugenio Mercuri
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

8.  Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests.

Authors:  Bart Bartels; Laura E Habets; Marloes Stam; Renske I Wadman; Camiel A Wijngaarde; Marja A G C Schoenmakers; Tim Takken; Erik H J Hulzebos; W Ludo van der Pol; Janke F de Groot
Journal:  BMC Neurol       Date:  2019-02-09       Impact factor: 2.474

9.  A video game based hand grip system for measuring muscle force in children.

Authors:  Mark Gotthelf; DeWayne Townsend; William Durfee
Journal:  J Neuroeng Rehabil       Date:  2021-07-10       Impact factor: 4.262

10.  A continuous repetitive task to detect fatigability in spinal muscular atrophy.

Authors:  Marloes Stam; Renske I Wadman; Bart Bartels; Maureen Leeuw; Henk-Jan Westeneng; Camiel A Wijngaarde; Leonard H van den Berg; W Ludo van der Pol
Journal:  Orphanet J Rare Dis       Date:  2018-09-12       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.